Next step for the Nanopatch

November 20, 2013

In 2012, using funds from his Rolex Award, Laureate Mark Kendall tested the usability and thermo-stability of his vaccine patch in a trial (without using vaccine) in Papua New Guinea. This “mock” trial resulted in key lessons on the use of the Nanopatch in the developing world, which have been applied to design improvements. Kendall and his team are now advancing the Nanopatch to human clinical trials.

Learn more about Mark Kendall

No Comments

Leave a Comment